Overview

A Clinical Study to Evaluate the Drug Interaction Between YZJ-1139 Tablets and Escitalopram Oxalate Tablets

Status:
ACTIVE_NOT_RECRUITING

Trial end date:
2025-01-01

Target enrollment:

Participant gender:

Summary

Primary Objective 1\) To evaluate the pharmacodynamic interaction between YZJ-1139 tablets and Escitalopram oxalate tablets in healthy subjects; 2) To evaluate the pharmacokinetic interaction between YZJ-1139 tablets and Escitalopram oxalate tablets in healthy subjects; To observe the safety of YZJ-1139 tablets taken together with Escitalopram oxalate tablets.

Phase:

PHASE1

Details

Lead Sponsor:

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

Treatments:

Escitalopram